TipRanks
ProKidney (PROK)
NASDAQ:PROK
US Market
PROK
ProKidney
RESEARCH TOOLSreports
Want to see PROK full AI Analyst Report?

ProKidney (PROK) Stock News & Sentiment

374 Followers
ProKidney shareholders reaffirm board and auditor at 2026 meeting
Premium
Company Announcements
ProKidney shareholders reaffirm board and auditor at 2026 meeting
4M ago
8K
PROK
Analyst Maintains Sell on ProKidney Amid Single-Asset Risk and Long Path to 2028 BLA, Keeps $1 Price Target Below Market
Premium
Ratings
Analyst Maintains Sell on ProKidney Amid Single-Asset Risk and Long Path to 2028 BLA, Keeps $1 Price Target Below Market
5M ago
PROK
ProKidney Highlights Progress in Pivotal Phase 3 CKD Trial
Premium
Company Announcements
ProKidney Highlights Progress in Pivotal Phase 3 CKD Trial
5M ago
8K
PROK
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PROK Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
PROK
Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability
Premium
Company Announcements
Trade Policy Risks: How Evolving U.S. Tariffs and Export Rules Threaten ProKidney Corp.’s Supply Chain and Financial Stability
7M ago
PROK
ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating
Premium
Ratings
ProKidney: Extended Development Timeline and Deferred Catalysts Support Balanced Hold Rating
7M ago
PROK
Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney
Premium
Ratings
Optimized PROACT 1 Design, Preserved Statistical Power, and Clear Regulatory Path Support Buy Rating on ProKidney
8M ago
PROK
More PROK News >

PROK News on the Web

ProKidney Insider Makes a Big Move With Major Stock Sale
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: ProKidney (PROK), Crinetics Pharmaceuticals (CRNX) and Alumis Inc. (ALMS)
TipRanks News
Bullish
ProKidney appoints Kenneth Locke as chief technical officer
TipRanks News
Neutral
ProKidney shareholders reaffirm board and auditor at 2026 meeting
TipRanks News
Neutral
ProKidney (PROK) Receives a Buy from Guggenheim
TipRanks News
Bullish
Is ProKidney (PROK) Attractive After Q1 2026 Beat? EPS -$0.14 vs -$0.15 est (beat); Revenue $0. ...
GuruFocus News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioMarin Pharmaceutical (BMRN) and ProKidney (PROK)
TipRanks News
Bullish
Analyst Maintains Sell on ProKidney Amid Single-Asset Risk and Long Path to 2028 BLA, Keeps $1 Price Target Below Market
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PROK’s Media Buzz Sentiment?
Currently, no data Available
What is PROK’s weekly average amount of articles?
In an average week, 0.25 articles about PROK are published.
    What is PROK’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    REGNRegeneron
    QTTBQ32 Bio
    NVSNovartis
    RHHVFRoche Holding AG
    KRROKorro Bio
    Showing the stocks with the most bullish news sentiment over the past week